Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. TLT
9. PMTS
10. QQQ

Go back to Ovid Therapeutics Expands Epilepsy Franchise with Novel KCC2 Activators
(NASDAQ: OVID) Delayed: 2.65 +0.02 (0.76%)
Previous Close $2.63    52 Week High $ 
Open $2.73    52 Week Low $ 
Day High $2.73    P/E N/A 
Day Low $2.64    EPS $ 
Volume 286,897